Akerman Laboratories advances biomedical research to create accessible, data-driven diagnostics and therapies, targeting complex or late-diagnosed diseases to improve detection and outcomes.
Our work is led by an active NIH funded Principal Investigator and departmental director of research with NIH reviewer experience, ensuring guidance reflects real study section expectations—not generic grant editing.
Our research program develops accessible, data-driven diagnostics and non-surgical therapeutic strategies for many complex cardiovascular disease, with a primary focus on aortic aneurysm.
All experimental work is conducted in the Akerman Laboratory at the University of North Carolina at Chapel Hill (Medical Biomolecular Research Building), a fully integrated space.
Our projects translate cutting-edge research into practical solutions, tackling complex diseases with innovative diagnostics, therapies, and strategies that make a real-world impact.
Business Laboratory Director and Principal Investigator
Adam Akerman, PhD, is an Assistant Professor in the Department of Surgery and Director of Research for the Department of Surgery at the University of North Carolina at Chapel Hill, where he also serves as...
Kyle C. Alexander serves as Director of Research Operations, providing end-to-end oversight of study execution, regulatory compliance, and data integration across the research program...
Elizabeth Collins serves as Laboratory Manager and Senior Research Specialist, providing technical, operational, and regulatory leadership across the research program. She is responsible for quality assurance, safety...